Faculty of Health, Social Care and Education
Application Portal
Drugs and Patient Group Directions | PHA702 | Level 7 | Credits 15 | 2021/22
Faculty of Health, Social Care and Education
Application Portal
Drugs and Patient Group Directions | PHA702 | Level 7 | Credits 15 | 2021/22
22/02/2022 | Cohort 25 (Start March 2021) | Intake Closed
22/02/2022 (Online), 01/03/2022 (Online), 08/03/2022 (Online), 15/03/2022 (Online), 22/03/2022 (Online)


For more information regarding the Covid pandemic and how it might affect you please visit this page - https://www.healthcare.ac.uk/courses/covid-update/


This module is intended for clinical practitioners from a range of backgrounds who are administering medicines to patients in a range of settings. In the MSc ACP Pathway it is compulsory for those without non-medical prescribing.  It may also be taken as a free standing module.

It will be typically offered on pathways of education that do not include formal prescribing but may serve as a foundation of education for aspiring prescribers in the future. The module will explore the underpinning science behind medicine management and consider the safe practice of administration of medicines under PGDs in different clinical settings.

• To extend the learner’s capacity to effectively supply and administer medicines, including those under PGDs.
• To extend the learner’s understanding of the underpinning pharmacological principles of medicines management 
• To extend the learner’s capacity to consider drug therapeutic actions, adverse effects and important interactions to promote safe, patient-centred practice


Programme entry requirements


Part 1: Single best answer Multiple Choice Examination and Part 2: Case Presentation

Learning Outcomes
  1. Safely and efficiently apply drug guidelines to a series of complex patient presentations.
  2. Critically relate key pharmacological principles to a range of patient presentations.
  3. Critically discuss the pharmacology of medicines in relation to specific patient groups, including the risk-benefit analysis.
  4. Critically discuss the evidence base and legalities that relates to key identified drugs used in clinical practice.
  5. Critically reflect upon their own experience to enhance the safe and effective use of an extended range of drugs in clinical practice.
  6. Analyse critically system and organisational features that could be refined and propose improvements to allow for safe and effective drug use in clinical practice.



Course Notes

As a consequence of the Covid-19 pandemic, your course may now have to be initially delivered partly online. Please use this link to see what the technology requirements are.




Apply Now
Enquire Now
Course Leader
Name: Daniel Creton
Mode of Delivery
Blended Learning. On-Campus sessions subject to change. If government advice changes, we may need to update our plans. If we do so, we will update this information, and will keep current students and offer holders informed by email.
Apply Now
Enquire Now